LTC pharmacies seek key role in COVID vaccine distribution
By
Alicia Lasek
Aug 27, 2020
Long-term care pharmacies now have a voice in federal decisions about COVID vaccine delivery to nursing homes and assisted living communities, says the American Society of Consultant Pharmacists.
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...
LTC pharmacists expect to play major role in COVID-19 vaccine distribution, administration
By
Kimberly Marselas
Sep 13, 2020
America’s long-term care pharmacists are preparing to play a major role in the distribution and administration of a COVID-19 vaccine, from moving vials to facilities to educating providers on packaging...
Provider groups develop heat map to aid coronavirus response; FEMA to deliver PPE
By
Danielle Brown
Apr 29, 2020
A newly-developed heat map of coronavirus cases in U.S. nursing homes and assisted living facilities will help to prioritize much-needed personal protective equipment and testing supplies for hard-hit...
New White House vaccine push could elevate LTC pharmacist role
By
Joe Bush
Oct 26, 2022
A pharmacy expert is hopeful a new White House push for vaccinations will empower long-term care pharmacists to play a continued role in COVID prevention and treatment.
Opt-in COVID vaccine program kicks off; Feds partner with CVS, Walgreens
By
Alicia Lasek
Oct 19, 2020
Long-term care facilities nationwide can voluntarily opt in to a free pharmacy partnership program that will provide and administer future COVID-19 vaccines on site, federal officials announced Friday.
‘Already skeptical’ nursing home workers may need persuading after J&J shots resume, industry leaders...
By
Danielle Brown
Apr 26, 2021
Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.